Yingjuan Lu, Ph.D.

Affiliations: 
2000 Purdue University, West Lafayette, IN, United States 
Area:
ligand-targeted imaging and therapeutic agents for the diagnosis and treatment of important human diseases
Google:
"Yingjuan Lu"
Mean distance: 12.9
 
SNBCP

Parents

Sign in to add mentor
Philip S. Low grad student 2000 Purdue
 (Exploring the potential of folate targeting in anticancer therapies.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lu YJ, Wheeler LW, Chu H, et al. (2021) Targeting folate receptor beta on monocytes/macrophages renders rapid inflammation resolution independent of root causes. Cell Reports. Medicine. 2: 100422
Elo P, Li XG, Liljenbäck H, et al. (2021) Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis. Journal of Neuroinflammation. 18: 30
Chu H, Shillingford JM, Reddy JA, et al. (2019) Detecting functional and accessible folate receptor expression in cancer and polycystic kidneys. Molecular Pharmaceutics
Lee YG, Chu H, Lu Y, et al. (2019) Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters. Nature Communications. 10: 2681
Lu YJ, Chu H, Wheeler LW, et al. (2019) Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies. Frontiers in Oncology. 9: 151
Chu H, Lu Y, Lee YG, et al. (2018) Abstract 2546: Regulation of CAR-T cell therapy in real time using bispecific small molecule adaptors and monospecific competitors Cancer Research. 78: 2546-2546
Lu Y, Wheeler LW, Cross VA, et al. (2017) Abstract 4574: Combinatorial strategies of folate receptor-targeted chemotherapy guided by improved understanding of tumor microenvironment and immunomodulation Cancer Research. 77: 4574-4574
Chu H, Shillingford JM, Parker N, et al. (2017) Abstract 4017: Development and application of an immunohistochemistry-based assay for evaluating functional and accessible folate receptor expressionin vivo Cancer Research. 77: 4017-4017
Lu Y, Johnson TP, Wheeler LW, et al. (2017) Abstract 3670: Treatment of epithelial ovarian cancer with folate receptor (α/β) targeted chemotherapy is enhanced by CTLA-4 blockade: Learning from animal models Cancer Research. 77: 3670-3670
Lu Y, Parker NL, Chu H, et al. (2017) Abstract 2057: Evaluation of anti-tumor efficacy of EC1456 in low-passage and pre-treated patient-derived xenograft models of triple-negative breast cancer Cancer Research. 77: 2057-2057
See more...